Harry Fisher

570 total citations
11 papers, 442 citations indexed

About

Harry Fisher is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Harry Fisher has authored 11 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Harry Fisher's work include Cardiac, Anesthesia and Surgical Outcomes (2 papers), Testicular diseases and treatments (2 papers) and Nausea and vomiting management (2 papers). Harry Fisher is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (2 papers), Testicular diseases and treatments (2 papers) and Nausea and vomiting management (2 papers). Harry Fisher collaborates with scholars based in United States and Australia. Harry Fisher's co-authors include D L Trump, Christine E. Sheehan, Patrick J. Loehrer, C R Nichols, Jonathan Greer, Ronald P. Kaufman, Jeffrey S. Ross, Janet Andersen, Edward A. Stadtmauer and Hillard M. Lazarus and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Harry Fisher

11 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Fisher United States 8 164 155 136 89 58 11 442
Hiroyuki Yamaoka Japan 13 103 0.6× 81 0.5× 69 0.5× 146 1.6× 24 0.4× 37 471
G�nther Gastl Austria 5 95 0.6× 61 0.4× 210 1.5× 114 1.3× 22 0.4× 8 441
Yosuke Komoto Japan 10 84 0.5× 87 0.6× 443 3.3× 201 2.3× 142 2.4× 16 726
Kunio Uematsu Japan 13 108 0.7× 273 1.8× 93 0.7× 136 1.5× 71 1.2× 43 598
S Valpreda Italy 8 68 0.4× 110 0.7× 149 1.1× 45 0.5× 16 0.3× 12 432
Celia Mor Israel 14 114 0.7× 60 0.4× 100 0.7× 132 1.5× 71 1.2× 25 399
C Henkle United States 7 173 1.1× 105 0.7× 194 1.4× 184 2.1× 61 1.1× 8 707
Hidekazu Takiuchi Japan 9 79 0.5× 84 0.5× 109 0.8× 142 1.6× 102 1.8× 32 499
Toshiaki Kinouchi Japan 13 290 1.8× 143 0.9× 248 1.8× 88 1.0× 15 0.3× 62 518
Su Y. Kim United States 9 99 0.6× 60 0.4× 119 0.9× 88 1.0× 67 1.2× 11 391

Countries citing papers authored by Harry Fisher

Since Specialization
Citations

This map shows the geographic impact of Harry Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Fisher more than expected).

Fields of papers citing papers by Harry Fisher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Fisher. The network helps show where Harry Fisher may publish in the future.

Co-authorship network of co-authors of Harry Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Fisher. A scholar is included among the top collaborators of Harry Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Fisher. Harry Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Fisher, Harry, et al.. (2024). Recent advances in the investigation of fusion RNAs and their role in molecular pathology of cancer. The International Journal of Biochemistry & Cell Biology. 168. 106529–106529. 1 indexed citations
2.
Kallakury, Bhaskar, Christine E. Sheehan, Robert A. Ambros, et al.. (1998). Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas.. Journal of Clinical Oncology. 16(4). 1302–1309. 58 indexed citations
5.
Kallakury, Bhaskar, Thomas P. Brien, Charles V. Lowry, et al.. (1997). Telomerase Activity in Human Benign Prostate Tissue and Prostatic Adenocarcinomas. Diagnostic Molecular Pathology. 6(4). 192–198. 35 indexed citations
6.
Yeap, B.Y., Thomas P. Davis, Ronald H. Blum, et al.. (1996). Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.. Journal of Clinical Oncology. 14(8). 2250–2257. 104 indexed citations
7.
Ross, Jeffrey, et al.. (1995). E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder*1. Human Pathology. 26(9). 940–944. 52 indexed citations
8.
Goldberg, Michael R., David Heimbrook, Paul Russo, et al.. (1995). Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer.. PubMed. 1(1). 57–61. 42 indexed citations
9.
Fisher, Harry. (1993). Management of penile carcinoma: the case for selective application of inguinal lymph node dissection in stages T1-T4.. PubMed. 11(2). 74–9. 5 indexed citations
10.
Solis, Otelo G., et al.. (1992). DNA ploidy of oncocytic-granular renal cell carcinomas and renal oncocytomas by image analysis.. PubMed. 116(2). 154–8. 9 indexed citations
11.
Nichols, C R, Janet Andersen, Hillard M. Lazarus, et al.. (1992). High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.. Journal of Clinical Oncology. 10(4). 558–563. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026